Correlation Between Oncimmune Holdings and DXC Technology

Can any of the company-specific risk be diversified away by investing in both Oncimmune Holdings and DXC Technology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Oncimmune Holdings and DXC Technology into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Oncimmune Holdings plc and DXC Technology Co, you can compare the effects of market volatilities on Oncimmune Holdings and DXC Technology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Oncimmune Holdings with a short position of DXC Technology. Check out your portfolio center. Please also check ongoing floating volatility patterns of Oncimmune Holdings and DXC Technology.

Diversification Opportunities for Oncimmune Holdings and DXC Technology

0.31

Correlation Coefficient

Oncimmune Holdings  DXC Technology

Weak diversification

The 3 months correlation between Oncimmune and DXC is 0.31. Overlapping area represents the amount of risk that can be diversified away by holding Oncimmune Holdings plc and DXC Technology Co in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on DXC Technology and Oncimmune Holdings is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Oncimmune Holdings plc are associated (or correlated) with DXC Technology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of DXC Technology has no effect on the direction of Oncimmune Holdings i.e., Oncimmune Holdings and DXC Technology go up and down completely randomly.

Pair Corralation between Oncimmune Holdings and DXC Technology

Assuming the 90 days trading horizon Oncimmune Holdings plc is expected to under-perform the DXC Technology. In addition to that, Oncimmune Holdings is 2.4 times more volatile than DXC Technology Co. It trades about -0.17 of its total potential returns per unit of risk. DXC Technology Co is currently generating about -0.18 per unit of volatility. If you would invest  2,147  in DXC Technology Co on October 12, 2024 and sell it today you would lose (123.00) from holding DXC Technology Co or give up 5.73% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

Oncimmune Holdings plc  vs.  DXC Technology Co

Oncimmune Holdings plc

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Oncimmune Holdings plc has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest uncertain performance, the Stock's technical and fundamental indicators remain sound and the latest tumult on Wall Street may also be a sign of longer-term gains for the firm shareholders.

DXC Technology

Risk-Adjusted Performance

0 of 100

Weak

Over the last 90 days DXC Technology Co has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable basic indicators, DXC Technology is not utilizing all of its potentials. The newest stock price uproar, may contribute to short-horizon losses for the private investors.

Pair Trading with Oncimmune Holdings and DXC Technology

The main advantage of trading using opposite Oncimmune Holdings and DXC Technology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Oncimmune Holdings position performs unexpectedly, DXC Technology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in DXC Technology will offset losses from the drop in DXC Technology's long position.

The idea behind Oncimmune Holdings plc and DXC Technology Co pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.